BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10834147)

  • 1. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
    Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H
    Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
    Abe T; Fukuoka T; Sato Y; Ito K; Sei M
    Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of biapenem against recent clinical isolates].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J; Inoue M; Nishino T; Watanabe N; Uehara N; Yoshida H; Imafuku Y; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Oguri T; Kumasaka K; Okada J; Hirata Y; Uchida K; Kawaguchi R; Ohtaki Y; Ishigo S; Okamoto E; Murakami E; Matsuoka K; Tokuda K; Saeki H
    Jpn J Antibiot; 1997 Aug; 50(8):683-703. PubMed ID: 9339395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J; Shibano T; Satou S; Inoue M; Kobayashi I; Takahashi A; Yomoda S; Nishino T; Oguri T; Watanabe N; Uehara N; Kumasaka K; Yoshida H; Imafuku Y; Kobayasi Y; Okada J; Tokuda K; Hirata Y; Nakasaki N; Hongo T; Kawaguchi R; Ohtaki Y; Sasaki T; Matsumoto N; Saeki H
    Jpn J Antibiot; 1999 Apr; 52(4):279-91. PubMed ID: 10396685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vitro activity of panipenem against clinical isolates in 2006].
    Yoshida S; Koga T; Kakuta M; Kobayashi I; Matsuzaki K; Urabe E; Omika K; Hasegawa M; Sato Y
    Jpn J Antibiot; 2008 Feb; 61(1):1-17. PubMed ID: 18536215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
    Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K
    Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K
    Jpn J Antibiot; 2001 Sep; 54(9):473-90. PubMed ID: 11729712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial activities of meropenem against clinically isolated strains].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activities of carbapenems against clinical isolates].
    Murase M
    Jpn J Antibiot; 1999 Nov; 52(11):667-79. PubMed ID: 10659443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2010)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):85-104. PubMed ID: 26182813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J; Inoue M; Nishino T; Watanabe N; Uehara N; Yoshida H; Imafuku Y; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Oguri T; Kumasaka K; Kobayasi Y; Okada J; Hirata Y; Nakasaki N; Kawaguchi R; Ohtaki Y; Ishigo S; Okamoto E; Murakami E; Matsuoka K; Saeki H
    Jpn J Antibiot; 1998 Feb; 51(2):47-68. PubMed ID: 9575436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.